Roth Capital Analysts Give BioDelivery Sciences International, Inc. (BDSI) a $5.00 Price Target


The brokerage presently has a "buy" rating on the specialty pharmaceutical company's stock. Roth Capital's target price points to a potential upside of 112.77% from the stock's previous close.



from Biotech News